REVELATION BIOSCIENCES, INC. (REVB)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

0.76 on 9 Oct 2026

0 buys0 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$8.91M

Free cash flow

$8.27M

Return on equity

-100.6%

Return on capital

-80.9%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
8 Dec 2023	TIDMARSH GEORGE F Director	Sold at will	$14.44K	100%
16 Oct 2023	TIDMARSH GEORGE F Director	Sold at will	$7.24K	20.7%
16 Oct 2023	TIDMARSH GEORGE F Director	Sold at will	$1.20K	6.2%
28 Sep 2023	TIDMARSH GEORGE F Director	Sold at will	$986.01	3.3%
18 Sep 2023	TIDMARSH GEORGE F Director	Sold at will	$2.96K	9.2%
15 Sep 2023	TIDMARSH GEORGE F Director	Sold at will	$6.94K	18.0%

37out of 100

Profitability 0

Financial strength 70

Growth n/a

Insiders 50

Strongest on financial strength (70), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan